102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Barlek MH, Gillis DC, Egner SA, Maragos SL, Karver MR, Stupp SI, Tsihlis ND, Kibbe MR. Systemic peptide amphiphile nanofiber delivery following subcutaneous injection. Biomaterials. 303: 122401. PMID 38006645 DOI: 10.1016/j.biomaterials.2023.122401  0.378
2022 Ledford BT, Akerman AW, Sun K, Gillis DC, Weiss JM, Vang J, Willcox S, Clemons TD, Sai H, Qiu R, Karver MR, Griffith JD, Tsihlis ND, Stupp SI, Ikonomidis JS, ... Kibbe MR, et al. Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms. Acs Nano. PMID 35504018 DOI: 10.1021/acsnano.1c06258  0.427
2021 Peters EB, Karver MR, Sun K, Gillis DC, Biswas S, Clemons TD, He W, Tsihlis ND, Stupp SI, Kibbe MR. Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche. Advanced Therapeutics. 4. PMID 34926792 DOI: 10.1002/adtp.202100103  0.422
2021 Marulanda K, Mercel A, Gillis DC, Sun K, Gambarian M, Roark J, Weiss J, Tsihlis ND, Karver MR, Centeno SR, Peters EB, Clemons TD, Stupp SI, McLean SE, Kibbe MR. Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice. Advanced Healthcare Materials. e2100302. PMID 34061473 DOI: 10.1002/adhm.202100302  0.409
2021 Mercel AI, Marulanda K, Gillis DC, Sun K, Clemons TD, Willcox S, Griffith J, Peters EB, Karver MR, Tsihlis ND, Maile R, Stupp SI, Kibbe MR. Development of novel nanofibers targeted to smoke-injured lungs. Biomaterials. 274: 120862. PMID 33975274 DOI: 10.1016/j.biomaterials.2021.120862  0.379
2020 Peters EB, Kibbe MR. Nanomaterials to Resolve Atherosclerosis. Acs Biomaterials Science & Engineering. 6: 3693-3712. PMID 33463318 DOI: 10.1021/Acsbiomaterials.0C00281  0.307
2020 Kassam HA, Bahnson EM, Cartaya A, Jiang W, Avram MJ, Tsihlis ND, Stupp SI, Kibbe MR. Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applications. Pharmacology Research & Perspectives. 8: e00672. PMID 33090704 DOI: 10.1002/prp2.672  0.769
2020 Saini SK, Li L, Peek CB, Kosmac K, Polonsky TS, Tian L, Criqui MH, Ferrucci L, Guralnik JM, Kibbe M, Sufit RL, Leeuwenburgh C, McDermott MM. Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Experimental Gerontology. 111048. PMID 32755612 DOI: 10.1016/J.Exger.2020.111048  0.311
2020 Klein MK, Kassam HA, Lee RH, Bergmeier W, Peters EB, Gillis DC, Dandurand BR, Rouan JR, Karver MR, Struble MD, Clemons TD, Palmer LC, Gavitt B, Pritts TA, Tsihlis ND, ... ... Kibbe MR, et al. Development of Optimized Tissue Factor-Targeted Peptide Amphiphile Nanofibers to Slow Non-Compressible Torso Hemorrhage. Acs Nano. PMID 32469498 DOI: 10.1021/Acsnano.9B09243  0.519
2020 Kassam HA, Gillis DC, Dandurand BR, Karver MR, Tsihlis ND, Stupp SI, Kibbe MR. Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury. Nanomaterials (Basel, Switzerland). 10. PMID 32121105 DOI: 10.3390/Nano10030420  0.555
2019 Mansukhani NA, Peters EB, So MM, Albaghdadi MS, Wang Z, Karver MR, Clemons TD, Laux JP, Tsihlis ND, Stupp SI, Kibbe MR. Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis. Macromolecular Bioscience. e1900066. PMID 31066494 DOI: 10.1002/Mabi.201900066  0.493
2019 Peters EB, Tsihlis ND, Karver MR, Chin SM, Musetti B, Ledford BT, Bahnson EM, Stupp SI, Kibbe MR. Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery. Advanced Healthcare Materials. e1801545. PMID 30620448 DOI: 10.1002/Adhm.201801545  0.466
2019 Wang Z, Mansukhani NA, Emond ZM, Varu VN, Chen A, Morgan CE, Vercammen JM, Kibbe MR. Endoluminal Atherosclerotic Plaque Debulking Using Enzymatic and Ultrasonic Energy. The Journal of Surgical Research. 233: 335-344. PMID 30502268 DOI: 10.1016/J.Jss.2018.08.012  0.322
2019 Mansukhani NA, Peters EB, So MM, Albaghdadi MS, Wang Z, Karver MR, Clemons TD, Laux JP, Tsihlis ND, Stupp SI, Kibbe MR. Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis Macromolecular Bioscience. 19: 1970016. DOI: 10.1002/mabi.201970016  0.401
2018 So MM, Mansukhani NA, Peters EB, Albaghdadi MS, Wang Z, Pérez CMR, Kibbe MR, Stupp SI. Peptide Amphiphile Nanostructures for Targeting of Atherosclerotic Plaque and Drug Delivery. Advanced Biosystems. 2. PMID 30666317 DOI: 10.1002/adbi.201700123  0.41
2018 Morgan CE, Dombrowski AW, Rubert Peŕez CM, Bahnson ESM, Tsihlis ND, Jiang W, Jiang Q, Vercammen JM, Prakash VS, Pritts TA, Stupp SI, Kibbe MR. Correction to Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage. Acs Nano. 12: 11711. PMID 30481963 DOI: 10.1021/Acsnano.8B07028  0.471
2018 Gregory EK, Webb A, Vercammen JM, Kelly ME, Akar B, van Lith R, Bahnson EM, Jiang W, Ameer GA, Kibbe MR. Inhibiting intimal hyperplasia in prosthetic vascular grafts via immobilized all-trans retinoic acid. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29391231 DOI: 10.1016/J.Jconrel.2018.01.020  0.324
2018 Mansukhani NA, So M, Albaghdadi MS, Peters EB, Wang Z, Stupp SI, Kibbe MR. Abstract 330: Targeted Nanotherapy for the Treatment of Atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.330  0.455
2018 Motta F, Kalbaugh CA, Crowner J, Pascarella L, McGinigle KL, Marston WA, Kibbe MR, Farber MA. Superior Mesenteric and Celiac Artery Stenting Does Not Increase Complication Rate After Fenestrated or Branched Endovascular Aneurysm Repair Journal of Vascular Surgery. 67: e32-e33. DOI: 10.1016/J.Jvs.2017.11.021  0.306
2018 Kassam HA, Gillis DC, Moyer TJ, Tsihlis ND, Stupp SI, Kibbe MR. Systemic Delivery of a Novel Fractalkine Binding Peptide Amphiphile Nanofiber to Target Injured Vasculature Journal of the American College of Surgeons. 227: S296-S297. DOI: 10.1016/J.Jamcollsurg.2018.07.615  0.478
2018 Buglak N, Jiang W, Stupp S, Kibbe M, Bahnson EM. Improving arterial surgery outcomes: Combating restenosis with nanotechnology and redox modulation Free Radical Biology and Medicine. 120: S26. DOI: 10.1016/J.Freeradbiomed.2018.04.028  0.788
2017 McDermott MM, Leeuwenburgh C, Guralnik JM, Tian L, Sufit R, Zhao L, Criqui MH, Kibbe MR, Stein JH, Lloyd-Jones D, Anton SD, Polonsky TS, Gao Y, de Cabo R, Ferrucci L. Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. Jama Cardiology. PMID 28403379 DOI: 10.1001/Jamacardio.2017.0538  0.303
2017 Meyers MW, Rink JS, Jiang Q, Kelly ME, Vercammen JM, Thaxton CS, Kibbe MR. Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiological Reports. 5. PMID 28242820 DOI: 10.14814/Phy2.13128  0.388
2017 McDermott MM, Kibbe MR. Improving Lower Extremity Functioning in Peripheral Artery Disease: Exercise, Endovascular Revascularization, or Both? Jama. 317: 689-690. PMID 28241363 DOI: 10.1001/Jama.2016.20673  0.304
2016 McDermott MM, Kramer CM, Tian L, Carr J, Guralnik JM, Polonsky T, Carroll T, Kibbe M, Criqui MH, Ferrucci L, Zhao L, Hippe DS, Wilkins J, Xu D, Liao Y, et al. Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. Jacc. Cardiovascular Imaging. PMID 27838307 DOI: 10.1016/J.Jcmg.2016.08.012  0.331
2016 Bahnson ES, Havelka GE, Koo NC, Jiang Q, Kibbe MR. Periadventitial adipose tissue modulates the effect of PROLI/NO on neointimal hyperplasia. The Journal of Surgical Research. 205: 440-445. PMID 27664894 DOI: 10.1016/J.Jss.2016.06.074  0.755
2016 Tsihlis ND, Rodriguez MP, Jiang Q, Schwartz A, Flynn ME, Vercammen JM, Kibbe MR. Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats. The Journal of Surgical Research. 202: 413-21. PMID 27229117 DOI: 10.1016/J.Jss.2016.01.030  0.32
2015 Morgan CE, Dombrowski AW, Rubert Pérez CM, Bahnson ES, Tsihlis ND, Jiang W, Jiang Q, Vercammen JM, Prakash VS, Pritts TA, Stupp SI, Kibbe MR. Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage. Acs Nano. PMID 26700464 DOI: 10.1021/Acsnano.5B06025  0.775
2015 Ho KJ, Xiong L, Hubert NJ, Nadimpalli A, Wun K, Chang EB, Kibbe MR. Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury. Physiological Reports. 3. PMID 26660548 DOI: 10.14814/Phy2.12627  0.367
2015 Bahnson ES, Vavra AK, Flynn ME, Vercammen JM, Jiang Q, Schwartz AR, Kibbe MR. Long-Term Effect of PROLI/NO on the Proliferative and Phenotypic Kinetic Profile after Arterial Injury. Free Radical Biology & Medicine. PMID 26627935 DOI: 10.1016/J.Freeradbiomed.2015.11.027  0.795
2015 Bahnson ES, Kassam HA, Moyer TJ, Jiang W, Morgan CE, Vercammen JM, Jiang Q, Flynn ME, Stupp SI, Kibbe MR. Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis after Arterial Injury. Antioxidants & Redox Signaling. PMID 26593400 DOI: 10.1089/Ars.2015.6363  0.795
2015 Wang Z, Emond ZM, Flynn ME, Swaminathan S, Kibbe MR. Microparticle levels after arterial injury and NO therapy in diabetes. The Journal of Surgical Research. PMID 26490225 DOI: 10.1016/J.Jss.2015.08.025  0.349
2015 Moyer TJ, Kassam HA, Bahnson ES, Morgan CE, Tantakitti F, Chew TL, Kibbe MR, Stupp SI. Shape-Dependent Targeting of Injured Blood Vessels by Peptide Amphiphile Supramolecular Nanostructures. Small (Weinheim An Der Bergstrasse, Germany). 11: 2750-5. PMID 25649528 DOI: 10.1002/Smll.201403429  0.779
2015 Morales RC, Bahnson ES, Havelka GE, Cantu-Medellin N, Kelley EE, Kibbe MR. Sex-based differential regulation of oxidative stress in the vasculature by nitric oxide. Redox Biology. 4: 226-33. PMID 25617803 DOI: 10.1016/J.Redox.2015.01.007  0.774
2015 Bahnson ES, Koo N, Cantu-Medellin N, Tsui AY, Havelka GE, Vercammen JM, Jiang Q, Kelley EE, Kibbe MR. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 44: 8-17. PMID 25460325 DOI: 10.1016/J.Niox.2014.10.009  0.793
2015 Wasserman MA, Jiang Q, Rink J, Kibbe MR, Thaxton CS. Synthetically Engineered Targeted Gold Nanoparticles for the Prevention of Restenosis after Vascular Interventions Journal of the American College of Surgeons. 221: S185. DOI: 10.1016/J.Jamcollsurg.2015.07.440  0.365
2015 Bahnson EM, Flynn M, Vercammen JM, Kibbe MR. 81 - Long-Term Effect of PROLI/NO on the Proliferative and Phenotypic Kinetic Profile After Arterial Injury Free Radical Biology and Medicine. 87. DOI: 10.1016/J.Freeradbiomed.2015.10.121  0.317
2014 Morgan CE, Lee CJ, Chin JA, Eskandari MK, Morasch MD, Rodriguez HE, Helenowski IB, Kibbe MR. High-risk anatomic variables and plaque characteristics in carotid artery stenting. Vascular and Endovascular Surgery. 48: 452-9. PMID 25252921 DOI: 10.1177/1538574414551577  0.312
2014 Polonsky TS, Liu K, Tian L, Carr J, Carroll TJ, Berry J, Criqui MH, Ferrucci L, Guralnik JM, Kibbe MR, Kramer CM, Li F, Xu D, Zhao X, Yuan C, et al. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 237: 169-76. PMID 25240112 DOI: 10.1016/J.Atherosclerosis.2014.08.034  0.316
2014 Gregory EK, Webb AR, Vercammen JM, Flynn ME, Ameer GA, Kibbe MR. Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats. American Journal of Physiology. Heart and Circulatory Physiology. 307: H1419-29. PMID 25239800 DOI: 10.1152/Ajpheart.00914.2013  0.323
2014 van Lith R, Gregory EK, Yang J, Kibbe MR, Ameer GA. Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues. Biomaterials. 35: 8113-22. PMID 24976244 DOI: 10.1016/J.Biomaterials.2014.06.004  0.307
2014 Wang Z, Emond Z, Kibbe M. P208 - Endothelial microparticles as a measure of endothelial cell response to vascular injury and nitric oxide treatment Nitric Oxide. 42: 150. DOI: 10.1016/J.Niox.2014.09.149  0.32
2014 Bahnson E, Moyer T, Kassam H, Vercammen J, Stupp S, Kibbe M. A systemically-injected targeted nitric oxide-delivery vehicle durably inhibits neointimal hyperplasia after arterial injury Nitric Oxide. 42: 115-116. DOI: 10.1016/J.Niox.2014.09.052  0.789
2014 Wang Z, Emond ZM, Morgan CE, Kibbe MR. A Novel Atraumatic Method of Arterial Plaque Debulking Journal of Vascular Surgery. 60: 1108-1109. DOI: 10.1016/J.Jvs.2014.07.061  0.317
2014 Moreira ES, Koo NC, Martz J, Kibbe MR. Nitric Oxide Inhibits Neointimal Hyperplasia via Regulation of Superoxide Dismutase-1: In Vivo and In Vitro Evidence of Nitric Oxide-Mediated Redox Regulation Journal of Surgical Research. 186: 593. DOI: 10.1016/J.Jss.2013.11.551  0.304
2014 Streams J, Martinez J, Flynn M, Kibbe M. Nitric Oxide Mediated Inhibition of Sca-1+ Stem Cell Populations in Diabetes After Vascular Injury Journal of Surgical Research. 186: 691-692. DOI: 10.1016/J.Jss.2013.11.1070  0.313
2014 Bahnson EM, Morgan CE, Jiang W, Kassam HA, Moyer T, Vercammen J, Stupp SI, Kibbe MR. Safety and Efficacy of a Systemically-Injected Targeted Therapy for the Injured Vasculature Free Radical Biology and Medicine. 76: S78. DOI: 10.1016/J.Freeradbiomed.2014.10.279  0.461
2013 Tsihlis ND, Vavra AK, Martinez J, Lee VR, Kibbe MR. Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 35: 165-74. PMID 24149190 DOI: 10.1016/J.Niox.2013.10.005  0.35
2013 McDermott MM, Carroll TJ, Kibbe M, Kramer CM, Liu K, Guralnik JM, Keeling AN, Criqui MH, Ferrucci L, Yuan C, Tian L, Liao Y, Berry J, Zhao L, Carr J. Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. Jacc. Cardiovascular Imaging. 6: 687-94. PMID 23647796 DOI: 10.1016/J.Jcmg.2012.10.024  0.329
2013 Tsihlis ND, Kapadia MR, Vavra AK, Flannery WD, Oustwani CS, Jiang Q, Kibbe MR. Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature Journal of Vascular Surgery. 58: 179-186. PMID 23375434 DOI: 10.1016/J.Jvs.2012.10.066  0.303
2013 Havelka GE, Moreira ES, Rodriguez MP, Tsihlis ND, Wang Z, Martínez J, Hrabie JA, Kiefer LK, Kibbe MR. Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury. The Journal of Surgical Research. 180: 35-42. PMID 23164361 DOI: 10.1016/J.Jss.2012.10.048  0.374
2013 Daly CM, Lee CJ, Kibbe M, Chin J, Morasch M, Rodriguez H, Eskandari MK, Helenowski IB. High Risk Anatomic Variables and Plaque Characteristics in Carotid Artery Stenting Journal of Vascular Surgery. 57: 45S. DOI: 10.1016/J.Jvs.2013.02.172  0.306
2013 Havelka GE, Moreira ES, Rodriguez MP, Tsihlis ND, Wang Z, Martínez J, Hrabie JA, Keefer LK, Kibbe MR. Erratum: Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury (Journal of Surgical Research (2013) 180:1 (35-42)) Journal of Surgical Research. 183. DOI: 10.1016/J.Jss.2013.03.056  0.38
2013 Tsihlis ND, Freischlag KW, Kibbe MR. Nitric Oxide Prevents Adventitial Fibroblast Proliferation By Preventing UbcH10-Mediated Degradation of Cyclin A Journal of Surgical Research. 179: 331. DOI: 10.1016/J.Jss.2012.10.672  0.308
2013 Moreira E, Moyer T, Kassam H, Stupp S, Kibbe M. Synthesis and Characterization of a Targeted Nitric Oxide-Delivery Vehicle Journal of Surgical Research. 179: 202. DOI: 10.1016/J.Jss.2012.10.356  0.319
2013 Kassam HA, Moyer TJ, Boekhoven J, Chew TL, Stupp SI, Kibbe MR. Binding of an intravascular delivery vehicle for prevention of arterial restenosis is contingent on tertiary structure Journal of the American College of Surgeons. 217: S137. DOI: 10.1016/J.Jamcollsurg.2013.07.320  0.303
2012 Tsihlis ND, Kapadia MR, Vavra AK, Jiang Q, Fu B, Martinez J, Kibbe MR. Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 27: 50-8. PMID 22561112 DOI: 10.1016/J.Niox.2012.04.006  0.353
2012 Keldahl ML, Park MS, Garcia-Toca M, Wang CH, Kibbe MR, Rodriguez HE, Morasch MD, Eskandari MK. Does a contralateral carotid occlusion adversely impact carotid artery stenting outcomes? Annals of Vascular Surgery. 26: 40-5. PMID 21963325 DOI: 10.1016/J.Avsg.2011.07.005  0.315
2012 Tsihlis ND, Fu B, Kibbe MR. Nitric Oxide Prevents Vascular Smooth Muscle Cell Proliferation By Preventing UbcH10-Mediated Degradation of Cyclin A and Cyclin B Journal of Surgical Research. 172: 333. DOI: 10.1016/J.Jss.2011.11.882  0.304
2012 Gregory E, Martinez J, Flynn M, Jiang Q, Webb A, Ameer G, Kibbe M. A Novel All-Trans Retinoic Acid Perivascular Wrap Reduces Neointimal Hyperplasia Following Arterial Balloon Injury Journal of Surgical Research. 172: 268. DOI: 10.1016/J.Jss.2011.11.871  0.346
2012 Kassam HA, Moyer TJ, Chew TL, Stupp SI, Kibbe MR. A targeted systemic therapy for the prevention of arterial restenosis Journal of the American College of Surgeons. 215: S132. DOI: 10.1016/J.Jamcollsurg.2012.06.340  0.353
2011 Gregory EK, Vavra AK, Moreira ES, Havelka GE, Jiang Q, Lee VR, Van Lith R, Ameer GA, Kibbe MR. Antioxidants modulate the antiproliferative effects of nitric oxide on vascular smooth muscle cells and adventitial fibroblasts by regulating oxidative stress. American Journal of Surgery. 202: 536-40. PMID 21944289 DOI: 10.1016/J.Amjsurg.2011.06.018  0.31
2011 Havelka GE, Hogg ME, Martinez J, Banjeree MN, Jiang Q, Kibbe MR. Adventitial contributions of the extracellular signal-regulated kinase and Akt pathways to neointimal hyperplasia. American Journal of Surgery. 202: 515-9. PMID 21906720 DOI: 10.1016/J.Amjsurg.2011.06.022  0.354
2011 McDermott MM, Liu K, Carroll TJ, Tian L, Ferrucci L, Li D, Carr J, Guralnik JM, Kibbe M, Pearce WH, Yuan C, McCarthy W, Kramer CM, Tao H, Liao Y, et al. Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III). Jacc. Cardiovascular Imaging. 4: 730-9. PMID 21757163 DOI: 10.1016/J.Jcmg.2011.04.009  0.329
2011 Oustwani CS, Tsihlis ND, Vavra AK, Jiang Q, Martinez J, Kibbe MR. Nitric oxide increases lysine 48-linked ubiquitination following arterial injury. The Journal of Surgical Research. 170: e169-77. PMID 21737094 DOI: 10.1016/J.Jss.2011.05.032  0.314
2011 Havelka GE, Kibbe MR. The vascular adventitia: its role in the arterial injury response. Vascular and Endovascular Surgery. 45: 381-390. PMID 21571779 DOI: 10.1177/1538574411407698  0.326
2011 Vavra AK, Havelka GE, Martinez J, Lee VR, Fu B, Jiang Q, Keefer LK, Kibbe MR. Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 25: 22-30. PMID 21554972 DOI: 10.1016/J.Niox.2011.04.013  0.369
2011 Tsihlis ND, Oustwani CS, Vavra AK, Jiang Q, Keefer LK, Kibbe MR. Nitric Oxide Inhibits Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia by Increasing the Ubiquitination and Degradation of UbcH10 Cell Biochemistry and Biophysics. 60: 89-97. PMID 21448667 DOI: 10.1007/S12013-011-9179-3  0.39
2011 McDermott MM, Liu K, Carr J, Criqui MH, Tian L, Li D, Ferrucci L, Guralnik JM, Kramer CM, Yuan C, Kibbe M, Pearce WH, Berry J, McCarthy W, Liao Y, et al. Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) III. Circulation. Cardiovascular Imaging. 4: 246-52. PMID 21436300 DOI: 10.1161/Circimaging.110.962183  0.32
2011 Serrano MC, Vavra AK, Jen M, Hogg ME, Murar J, Martinez J, Keefer LK, Ameer GA, Kibbe MR. Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia. Macromolecular Bioscience. 11: 700-9. PMID 21341372 DOI: 10.1002/Mabi.201000509  0.331
2011 Tsihlis ND, Vavra AK, Oustwani CS, Martinez J, Kibbe MR. Ubiquitination of the Ubiquitin-Conjugating Enzyme UbcH10: in Vivo Characterization Following Arterial Injury Journal of Surgical Research. 165: 343. DOI: 10.1016/J.Jss.2010.11.077  0.331
2011 Moreira ES, Tsui A, Kibbe MR. Nitric Oxide Inhibits VSMC Proliferation following Arterial Injury via Modulation of Superoxide Dismutase-1 Free Radical Biology and Medicine. 51. DOI: 10.1016/J.Freeradbiomed.2011.10.114  0.391
2010 Garcia-Toca M, Naughton PA, Matsumura JS, Morasch MD, Kibbe MR, Rodriguez HE, Pearce WH, Eskandari MK. Endovascular repair of blunt traumatic thoracic aortic injuries: seven-year single-center experience. Archives of Surgery (Chicago, Ill. : 1960). 145: 679-83. PMID 20644131 DOI: 10.1001/Archsurg.2010.114  0.301
2010 Varu VN, Ahanchi SS, Hogg ME, Bhikhapurwala HA, Chen A, Popowich DA, Vavra AK, Martinez J, Jiang Q, Saavedra JE, Hrabie JA, Keefer LK, Kibbe MR. Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes. American Journal of Physiology. Heart and Circulatory Physiology. 299: H772-9. PMID 20562340 DOI: 10.1152/Ajpheart.01234.2009  0.303
2010 Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, Kibbe MR. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury Journal of Vascular Surgery. 51: 1248-1259. PMID 20223627 DOI: 10.1016/J.Jvs.2009.12.028  0.337
2010 Vavra A, Martinez J, Lee VR, Fu B, Jiang Q, Kibbe MR. PS202. Durable Effect of Nitric Oxide at Inhibiting Neointimal Hyperplasia Is due to Modulation of Cellular Populations Throughout the Arterial Wall Journal of Vascular Surgery. 51. DOI: 10.1016/J.Jvs.2010.02.187  0.351
2010 Moreira ES, Tsui A, Havelka G, Kibbe MR. Nitric Oxide Inhibits Neointimal Hyperplasia following Vascular Interventions via Differential Modulation of Superoxide Levels in the Arterial Wall Free Radical Biology and Medicine. 49. DOI: 10.1016/J.Freeradbiomed.2010.10.043  0.375
2009 Vavra AK, Kibbe MR. Women and peripheral arterial disease Women's Health. 5: 669-683. PMID 19863470 DOI: 10.2217/Whe.09.60  0.303
2009 Amaranto DJ, Abbas F, Krantz S, Pearce WH, Wang E, Kibbe MR. An evaluation of gender and racial disparity in the decision to treat surgically arterial disease. Journal of Vascular Surgery. 50: 1340-7. PMID 19837528 DOI: 10.1016/J.Jvs.2009.07.089  0.343
2009 Payvandi L, Dyer A, McPherson D, Ades P, Stein J, Liu K, Ferrucci L, Criqui MH, Guralnik JM, Lloyd-Jones D, Kibbe MR, Liang ST, Kane B, Pearce WH, Verta M, et al. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vascular Medicine (London, England). 14: 193-201. PMID 19651668 DOI: 10.1177/1358863X08101018  0.326
2009 Brown KE, Usman A, Kibbe MR, Morasch MD, Matsumura JS, Pearce WH, Amaranto DJ, Eskandari MK. Carotid stenting using tapered and nontapered stents: associated neurological complications and restenosis rates. Annals of Vascular Surgery. 23: 439-445. PMID 19128933 DOI: 10.1016/J.Avsg.2008.11.007  0.315
2009 Varu VN, Tsihlis ND, Kibbe MR. Basic science review: nitric oxide--releasing prosthetic materials. Vascular and Endovascular Surgery. 43: 121-131. PMID 18799500 DOI: 10.1177/1538574408322752  0.31
2008 Brown KE, Fanciullo DJ, Hicks T, Landau DS, Baraniewski HM, Morasch MD, Matsumura JS, Pearce WH, Eskandari MK, Kibbe MR. Carotid artery stenting compared to carotid endarterectomy performed exclusively in a veteran population: one center's experience with midterm results. Annals of Surgery. 248: 110-116. PMID 18580214 DOI: 10.1097/Sla.0B013E318176C49D  0.3
2008 Kapadia MR, Popowich DA, Kibbe MR. Modified Prosthetic Vascular Conduits Circulation. 117: 1873-1882. PMID 18391121 DOI: 10.1161/Circulationaha.107.714170  0.313
2008 Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, Martinez J, Popowich DA, Jiang Q, Hrabie JA, Saavedra JE, Keefer LK, Hulvat JF, Stupp SI, Kibbe MR. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. Journal of Vascular Surgery. 47: 173-82. PMID 18178471 DOI: 10.1016/J.Jvs.2007.09.005  0.54
2008 Pearce CG, Najjar SF, Kapadia MR, Murar J, Eng J, Lyle B, Aalami OO, Jiang Q, Hrabie JA, Saavedra JE, Keefer LK, Kibbe MR. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radical Biology & Medicine. 44: 73-81. PMID 18045549 DOI: 10.1016/J.Freeradbiomed.2007.09.010  0.396
2008 Kapadia MR, Aalami OO, Najjar SF, Jiang Q, Murar J, Lyle B, Eng JW, Kane B, Carroll T, Cahill PM, Kibbe MR. A reproducible porcine ePTFE arterial bypass model for neointimal hyperplasia. The Journal of Surgical Research. 148: 230-7. PMID 18028957 DOI: 10.1016/J.Jss.2007.08.003  0.331
2008 Tsihlis ND, Murar J, Flannery WD, Kapadia MR, Ahanchi SS, Martinez J, Jiang Q, Popowich DA, Saavedra JE, Keefer LK, Kibbe MR. QS359. The Diazeniumdiolate IPA/NO Moderates Neointimal Hyperplasia Following Vascular Interventions Via a Mechanism Distinct from Nitric Oxide Journal of Surgical Research. 144: 410. DOI: 10.1016/J.Jss.2007.12.613  0.315
2007 Popowich DA, Varu V, Kibbe MR. Nitric Oxide: What a Vascular Surgeon Needs to Know Vascular. 15: 324-335. PMID 18053416 DOI: 10.2310/6670.2007.00051  0.385
2007 Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia Journal of Vascular Surgery. 45: 64-73. PMID 17544026 DOI: 10.1016/J.Jvs.2007.02.027  0.334
2006 Schena S, Owens CA, Hassoun HT, Kibbe MR. Delayed Presentation of a Posttraumatic Superficial Femoral Artery Pseudoaneurysm Journal of the American College of Surgeons. 203: 250-251. PMID 16864037 DOI: 10.1016/J.Jamcollsurg.2006.02.016  0.316
2005 Longo GM, Kibbe MR. Aneurysms of the carotid artery. Seminars in Vascular Surgery. 18: 178-83. PMID 16360573 DOI: 10.1053/J.Semvascsurg.2005.09.002  0.341
2004 Morasch MD, Kibbe MR, Evans ME, Meadows WS, Eskandari MK, Matsumura JS, Pearce WH. Percutaneous repair of abdominal aortic aneurysm. Journal of Vascular Surgery. 40: 12-6. PMID 15218455 DOI: 10.1016/J.Jvs.2004.03.019  0.306
2003 Wang K, Kessler PD, Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Kibbe M, Kovesdi I, Brough DE, Topol EJ, Lincoff AM. Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 597-603. PMID 12718902 DOI: 10.1016/S1525-0016(03)00061-3  0.325
2001 Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, Makaroun MS, Billiar TR, Rhee RY. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia Journal of Vascular Surgery. 34: 156-165. PMID 11436090 DOI: 10.1067/Mva.2001.113983  0.323
2000 Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, Tzeng E. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. Journal of Vascular Surgery. 31: 1214-28. PMID 10842159 DOI: 10.1067/Mva.2000.105006  0.303
2000 Kibbe MR, Billiar TR, Tzeng E. Gene Therapy for Restenosis Circulation Research. 86: 829-833. PMID 10785503 DOI: 10.1161/01.Res.86.8.829  0.353
2000 Kibbe MR, Tzeng E. Nitric oxide synthase gene therapy in vascular pathology. Seminars in Perinatology. 24: 51-54. PMID 10709860 DOI: 10.1016/S0146-0005(00)80056-7  0.337
1999 Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury Cardiovascular Research. 43: 650-657. PMID 10690336 DOI: 10.1016/S0008-6363(99)00130-3  0.361
1999 Kibbe M, Billiar T, Tzeng E. Nitric oxide synthase gene transfer to the vessel wall. Current Opinion in Nephrology and Hypertension. 8: 75-81. PMID 9914863 DOI: 10.1097/00041552-199901000-00012  0.303
1999 Kibbe MR, Nie S, Yoneyama T, Hatakeyama K, Lizonova A, Kovesdi I, Billiar TR, Tzeng E. Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts. Surgery. 126: 323-329. DOI: 10.1016/S0039-6060(99)70172-8  0.342
1998 Shears LL, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, Tzeng E. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo Journal of the American College of Surgeons. 187: 295-306. PMID 9740187 DOI: 10.1016/S1072-7515(98)00163-X  0.384
Show low-probability matches.